How is AI transforming drug discovery chemistry?
Imagine you’re trying to find the correct key to unlock a treasure box, but there are billions of keys to…
Imagine you’re trying to find the correct key to unlock a treasure box, but there are billions of keys to…
What is Derek Nexus? Developed by Lhasa Limited, Derek Nexus is an expert-knowledge based system that draws on over 40…
What are neural networks? Neural networks (NNs) in various forms are very common nowadays, and specific architectures are used for…
How can I predict my compound’s absorption? The first of the ADMET properties relate to absorption. Understanding how a drug…
My hope is that these posts will be of interest to people who want to understand more of the nuts…
What are StarDrop and Semeta? Semeta is a tailored platform for DMPK scientists. It enables users to address key challenges…
Data curation for model building A model can only be as good as the data it has been trained on.…
Why focus on cytochrome P450 enzymes? CYPs are a ubiquitous superfamily of heme-containing monooxygenases responsible for approximately 70–80% of observed…
StarDrop — A Swiss Army knife for drug discovery It’s designed to fit right in with the other tools you…
Finding the right fit There’s no one-size-fits-all solution when it comes to data visualisation and analysis tools for drug development…
What’s the purpose of a predictive model? What’s the value of predictive models for drug discovery? Most of the undergraduate…
Discover which metabolite prediction software is best for your needs in this comprehensive guide from Optibrium. Compare top tools like Meteor Nexus, MetaSite, and StarDrop to make informed decisions for drug metabolism prediction
We’re often asked, “What’s the difference between QSAR and imputation models?”, so I’m going to explain how the methods differ, their advantages and disadvantages, and when each approach is applicable.
The joint ISSX/JSSX meeting is for researchers looking to gain a deeper understanding of drug metabolism and pharmacokinetics.
In this ebook we demonstrate our deployable AI discovery platform, Cerella™. Browse real-world stories of success from our collaborations with AstraZeneca, Genetech, Takeda Pharmaceuticals, Constellation Pharmaceuticals and many more.
Join Optibrium’s Chris Khoury at the 38th NMCS meeting in Seattle, 23-26 June